Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation

Reduced Cardiovascular Capacity and Resting Metabolic Rate in Men with Prostate Cancer Undergoing Androgen Deprivation: A Comprehensive Cross-Sectional Investigation

Objectives. To investigate if androgen deprivation therapy exposure is associated with additional risk factors for cardiovascular disease and metabolic treatment-related toxicities. Methods. One hundred and seven men (42–89 years) with prostate cancer undergoing androgen deprivation therapy complete...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bradley A. Wall, Daniel A. Galvão, Naeem Fatehee, Dennis R. Taaffe, Nigel Spry, David Joseph, Robert U. Newton
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Series:	Advances in Urology
Online Access:	http://dx.doi.org/10.1155/2015/976235
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
by: Katherine Neubecker, et al.
Published: (2017-01-01)

An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
by: Kristene Myklak, et al.
Published: (2011-01-01)

Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
by: Matthew E. Johnson, et al.
Published: (2012-01-01)

The Current Role of Androgen Deprivation in Patients Undergoing Dose-Escalated External Beam Radiation Therapy for Clinically Localized Prostate Cancer
by: Michael J. Smith, et al.
Published: (2012-01-01)

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
by: Lior Z. Braunstein, et al.
Published: (2014-01-01)

Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
by: Rahul Aggarwal, et al.
Published: (2022-01-01)

Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study
by: Alexander R. Lucas, et al.
Published: (2025-02-01)

Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial)
by: Robert U Newton, et al.
Published: (2022-06-01)

The Prognostic Importance of Prostate-Specific Antigen in Monitoring Patients Undergoing Maximum Androgen Blockage for Metastatic Prostate Cancer
by: Ahmet Kiper, et al.
Published: (2005-01-01)

High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy
by: Satoko Kojima, et al.
Published: (2021-01-01)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
by: Manish Kohli, et al.
Published: (2012-01-01)

Calcium Activation of the Androgen Receptor in Prostate Cells
by: Zeina W. Sharawi, et al.
Published: (2023-01-01)

Prostate Cancer Severity Associations with Neighborhood Deprivation
by: Charnita M. Zeigler-Johnson, et al.
Published: (2011-01-01)

Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only
by: Stefan Latz, et al.
Published: (2015-01-01)

CAG Expansion in Androgen Receptor Gene of Infertile Men in Erbil Governorate
by: Dashne Abdulla Salih, et al.
Published: (2023-01-01)

Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men
by: Pedro Fernandez, et al.
Published: (2012-01-01)

Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia
by: Yu Tong, et al.
Published: (2020-01-01)

Development of Novel Nomograms to Predict 5- and 7-Year Biochemical-Recurrence-Free Survival in High-Risk Prostate Cancer Patients After Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
by: Takanobu Utsumi, et al.
Published: (2025-01-01)

Androgen Receptor-Target Genes in African American Prostate Cancer Disparities
by: Bi-Dar Wang, et al.
Published: (2013-01-01)

The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
by: Jennifer H. Gunter, et al.
Published: (2012-01-01)

New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
by: Abhijit M. Godbole, et al.
Published: (2011-01-01)

Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – protocol for the ERADICATE study: a phase II randomised controlled trial
by: Oliver Schumacher, et al.
Published: (2025-01-01)

Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
by: Caihong Li, et al.
Published: (2025-02-01)

Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer
by: Alacia M. Voth, et al.
Published: (2017-05-01)

Elevated resting heart rate in adolescent men and risk of heart failure and cardiomyopathy
by: Martin Lindgren, et al.
Published: (2020-06-01)

AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer
by: Jiawei Zhang, et al.
Published: (2025-02-01)

SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer
by: Yuqian Yan, et al.
Published: (2025-01-01)

Altered spontaneous brain activity in children with deprivation amblyopia: a resting-state functional magnetic resonance imaging study
by: Yadong Li, et al.
Published: (2025-01-01)

Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
by: Renliang Yi, et al.
Published: (2016-01-01)

Exploring therapeutic strategies for androgen-independent prostate cancer using a magnetic coculture platform
by: Anjani Chavali, et al.
Published: (2025-06-01)

Association of Androgen-Receptor Gene Mutations with the Copy Number of Androgen-Receptor Silk Protein A Complex and Glutathione-S-Transferases T1 and M1 in Prostate Cancer Patients
by: Yan Zhang, et al.
Published: (2023-01-01)

Tailoring lipid management interventions to reduce inequalities in cardiovascular disease risk management in primary care for deprived communities in Northern England: a mixed-methods intervention development protocol
by: Julia L Newton, et al.
Published: (2022-07-01)

Area deprivation and premature cardiovascular mortality: a nationwide population-based study in South Korea
by: Hyeon Chang Kim, et al.
Published: (2024-04-01)

Insights into prostate cancer awareness and perceptions among men in Tshwane
by: L Nzombe, et al.
Published: (2024-06-01)

Transmembrane Prostate Androgen-Induced Protein 1 Molecular Modeling and Refinement Using Coarse-Grained Molecular Dynamics
by: Imam Adi Wicaksono, et al.
Published: (2025-01-01)

Associations of CAG repeat polymorphism in the androgen receptor gene with steroid hormone levels and anthropometrics among men: the role of the ethnic factor
by: L. V. Osadchuk, et al.
Published: (2024-03-01)

Prospective Study of Antibiotic Prophylaxis for Prostate Biopsy Involving >1100 Men
by: Rustom P. Manecksha, et al.
Published: (2012-01-01)

Symptom clusters and resting cardiovascular autonomic measures in adolescents: From acute concussion to recovery
by: Wenjie Ji, et al.
Published: (2024-11-01)

Methods of studying the cardiovascular system in students of a sports university in the process of recreational rest
by: Viacheslav Zaytzev, et al.
Published: (2022-06-01)

Effects of IL-6 and TNF-α Cytokines on Cell Proliferation in Androgen Dependent/Independent Prostate Cancer Cell Lines
by: Serhad Onat, et al.
Published: (2024-03-01)